Stephen Brannan
2019
In 2019, Stephen Brannan earned a total compensation of $1M as Chief Medical Officer at Karuna Therapeutics, a 59% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $217,025 |
|---|---|
| Option Awards | $409,964 |
| Salary | $394,082 |
| Other | $8,400 |
| Total | $1,029,471 |
Brannan received $410K in option awards, accounting for 40% of the total pay in 2019.
Brannan also received $217K in non-equity incentive plan, $394.1K in salary and $8.4K in other compensation.
Rankings
In 2019, Stephen Brannan's compensation ranked 9,154th out of 13,971 executives tracked by ExecPay. In other words, Brannan earned more than 34.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,154 out of 13,971 | 35th |
Division Manufacturing | 3,672 out of 5,701 | 36th |
Major group Chemicals And Allied Products | 1,390 out of 2,200 | 37th |
Industry group Drugs | 1,187 out of 1,886 | 37th |
Industry Pharmaceutical Preparations | 880 out of 1,398 | 37th |
Source: SEC filing on April 27, 2021.
Brannan's colleagues
We found three more compensation records of executives who worked with Stephen Brannan at Karuna Therapeutics in 2019.